BRIEF-Seres Therapeutics announces key findings from SER-109 Phase 2 study analyses

* Seres Therapeutics announces key findings from SER-109 Phase 2 study analyses [Source]

Publication Date: Tuesday, 31 January 2017 at 14:18:12

Origin: reuters.com

Category: rbssHealthcareNews

Topics: analyses, study, findings, announces, Therapeutics, SER-109 Phase, Seres, Phase, SER-109, BRIEF-Seres

Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/GWj7bsqXlXs/idUSFWN1FL0FY

Related Articles

Drugmakers look for reciprocal UK-EU regulation after Brexit

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:26:46

UPDATE 1-Opioid addiction implant maker Braeburn Pharma pulls IPO

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 18:10:46

BRIEF-Nestle Health Science plans to expand manufacturing facility in Eau Claire, Wi

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 17:45:15

BRIEF-Medivir says EGM backs redemption programme

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:54:21

BRIEF-Cymabay announces pricing of public offering of common stock

[ reuters.com ] rbssHealthcareNews, Thursday, 2 February 2017 at 16:37:22